Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1176

1.

Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis.

Sophocleous A, Marino S, Logan JG, Mollat P, Ralston SH, Idris AI.

J Biol Chem. 2015 Jul 20. pii: jbc.M115.649608. [Epub ahead of print]

2.

Hydroxytyrosol Inhibits Cannabinoid CB1 Receptor Gene Expression in 3T3-L1 Preadipocyte Cell Line.

Tutino V, Orlando A, Russo F, Notarnicola M.

J Cell Physiol. 2015 Jul 19. doi: 10.1002/jcp.25094. [Epub ahead of print]

PMID:
26189725
3.

Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects.

Patil KR, Goyal SN, Sharma C, Patil CR, Ojha S.

Curr Med Chem. 2015 Jul 16. [Epub ahead of print]

PMID:
26179998
4.

Validation of endogenous control reference genes for normalizing gene expression studies in endometrial carcinoma.

Ayakannu T, Taylor AH, Willets JM, Brown L, Lambert DG, McDonald J, Davies Q, Moss EL, Konje JC.

Mol Hum Reprod. 2015 Jun 29. pii: gav033. [Epub ahead of print]

PMID:
26124453
5.

Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release.

Gao F, Zhang LH, Su TF, Li L, Zhou R, Peng M, Wu CH, Yuan XC, Sun N, Meng XF, Tian B, Shi J, Pan HL, Li M.

Mol Neurobiol. 2015 Jun 25. [Epub ahead of print]

PMID:
26108183
6.

The use of cannabinoids as anticancer agents.

Velasco G, Hernández-Tiedra S, Dávila D, Lorente M.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 10. pii: S0278-5846(15)00119-0. doi: 10.1016/j.pnpbp.2015.05.010. [Epub ahead of print] Review.

7.

In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe.

Zhang S, Shao P, Ling X, Yang L, Hou W, Thorne SH, Beaino W, Anderson CJ, Ding Y, Bai M.

Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):246-58. eCollection 2015.

8.

[Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells].

Yan L, Li J, Zhao T, Wang H, Lai G.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jun;31(6):758-62. Chinese.

PMID:
26062417
9.

Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.

Chen L, Chen H, Li Y, Li L, Qiu Y, Ren J.

Oncol Rep. 2015 Jul;34(1):447-54. doi: 10.3892/or.2015.3973. Epub 2015 May 12.

PMID:
25975960
10.

AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells.

Carpi S, Fogli S, Romanini A, Pellegrino M, Adinolfi B, Podestà A, Costa B, Da Pozzo E, Martini C, Breschi MC, Nieri P.

Anticancer Drugs. 2015 Aug;26(7):754-62. doi: 10.1097/CAD.0000000000000246.

PMID:
25974027
11.

Evaluation of the anti-inflammatory and antioxidative potential of four fern species from China intended for use as food supplements.

Dion C, Haug C, Guan H, Ripoll C, Spiteller P, Coussaert A, Boulet E, Schmidt D, Wei J, Zhou Y, Lamottke K.

Nat Prod Commun. 2015 Apr;10(4):597-603.

PMID:
25973486
12.

Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.

Lanuti M, Talamonti E, Maccarrone M, Chiurchiù V.

PLoS One. 2015 May 13;10(5):e0126839. doi: 10.1371/journal.pone.0126839. eCollection 2015.

13.

The evolving role of the endocannabinoid system in gynaecological cancer.

Ayakannu T, Taylor AH, Willets JM, Konje JC.

Hum Reprod Update. 2015 Jul;21(4):517-535. Epub 2015 May 9. Review.

PMID:
25958409
14.

Downstream effects of endocannabinoid on blood cells: implications for health and disease.

Gasperi V, Evangelista D, Savini I, Del Principe D, Avigliano L, Maccarrone M, Catani MV.

Cell Mol Life Sci. 2015 May 10. [Epub ahead of print]

PMID:
25957591
15.

New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.

Manera C, Malfitano AM, Parkkari T, Lucchesi V, Carpi S, Fogli S, Bertini S, Laezza C, Ligresti A, Saccomanni G, Savinainen JR, Ciaglia E, Pisanti S, Gazzerro P, Di Marzo V, Nieri P, Macchia M, Bifulco M.

Eur J Med Chem. 2015 Jun 5;97:10-8. doi: 10.1016/j.ejmech.2015.04.034. Epub 2015 Apr 24.

PMID:
25935384
16.

Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.

Esain V, Kwan W, Carroll KJ, Cortes M, Liu SY, Frechette GM, Sheward LM, Nissim S, Goessling W, North TE.

Stem Cells. 2015 Aug;33(8):2596-612. doi: 10.1002/stem.2044. Epub 2015 May 26.

PMID:
25931248
17.

Differential role of cannabinoids in the pathogenesis of skin cancer.

Glodde N, Jakobs M, Bald T, Tüting T, Gaffal E.

Life Sci. 2015 Apr 25. pii: S0024-3205(15)00220-9. doi: 10.1016/j.lfs.2015.04.003. [Epub ahead of print]

PMID:
25921771
18.

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

McAllister SD, Soroceanu L, Desprez PY.

J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Epub 2015 Apr 28.

PMID:
25916739
19.

A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R.

Ling X, Zhang S, Shao P, Li W, Yang L, Ding Y, Xu C, Stella N, Bai M.

Biomaterials. 2015 Jul;57:169-78. doi: 10.1016/j.biomaterials.2015.04.018. Epub 2015 Apr 28.

PMID:
25916505
20.

Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.

Nabissi M, Morelli MB, Amantini C, Liberati S, Santoni M, Ricci-Vitiani L, Pallini R, Santoni G.

Int J Cancer. 2015 Apr 22. doi: 10.1002/ijc.29573. [Epub ahead of print]

PMID:
25903924
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk